# Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

> **NCT03080298** · PHASE2 · COMPLETED · sponsor: **Ivix LLX** · enrollment: 119 (actual)

## Conditions studied

- Hypoactive Sexual Desire Disorder (HSDD)

## Interventions

- **DRUG:** BP101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03080298
- **Lead sponsor:** Ivix LLX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-14
- **Primary completion:** 2017-04-04
- **Final completion:** 2017-07-25
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03080298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03080298, "Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03080298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*